Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Capital Expenditures (2018 - 2019)

Historic Capital Expenditures for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q4 2019 value amounting to $14000.0.

  • DiaMedica Therapeutics' Capital Expenditures rose 20769.23% to $14000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $22000.0, marking a year-over-year decrease of 5600.0%. This contributed to the annual value of $25000.0 for FY2024, which is 416.67% up from last year.
  • Latest data reveals that DiaMedica Therapeutics reported Capital Expenditures of $14000.0 as of Q4 2019, which was up 20769.23% from -$13000.0 recorded in Q4 2018.
  • In the past 5 years, DiaMedica Therapeutics' Capital Expenditures ranged from a high of $32000.0 in Q1 2018 and a low of -$13000.0 during Q4 2018